Skip to content

Author

Navya Pillikunte Doddareddy

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Impact of extranodal disease burden on survival following CAR-T therapy in relapsed/refractory large B-cell lymphoma: A propensity score-matched multi-center analysis.

Overall survival, CRS, ICANS, and sepsis rates were comparable between extranodal and nodal disease cohorts, and CAR-T therapy as equally effective in extranodal involvement should not influence treatment eligibility decisions.

Navya Pillikunte Doddareddy, Ranjit Sah · 0 citations
Open access Oct 2026

Comparative effectiveness of CAR-T cell therapy and CD20xCD3 bispecific antibodies in relapsed/refractory follicular lymphoma: A propensity score–matched real-world analysis.

639 Background: CD20×CD3 bispecific antibodies and chimeric antigen receptor T-cell (CAR-T) therapy have expanded treatment options for relapsed/refractory follicular lymphoma (R/R FL). Although both therapies demonstrate substantial clinical activity, comparative real-world data remain limited. We compared sur...

Navya Pillikunte Doddareddy, Ranjit Sah, G. Sorescu · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.